Rocio Garcia-Carbonero

27PUBLICATIONS
161CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionElectrical and electromagnetic methods in geophysics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Feb 26, 2026
Establishment of patient-derived xenografts for neuroendocrine tumors in the avian embryo model.

Nilakshi Kulathunga, Rusha Chakraborty, Yan Li

|Feb 20, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

Rocio Garcia-Carbonero, Marta Benavent, Paula Jimenez-Fonseca

|Nov 27, 2025
Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review.

Jorge H Hernandez-Felix, Monica Isabel Meneses-Medina, Rachel Riechelmann

|Nov 04, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.

Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade

|Sep 12, 2025
Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914).

Jaume Capdevila, Jorge Hernando, Javier Molina-Cerrillo

|Jun 06, 2025
Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer.

Beatriz Rubio-Cuesta, Carlos Carretero-Puche, Patricia Llamas

Pageof 5

Frequent Collaborators

4 joint publications

Beatriz Soldevilla

3 joint publications

Jaume Capdevila

3 joint publications

Beatriz Anton-Pascual

3 joint publications

Alberto Lens-Pardo